Gene · 60485
Papers1,483
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,483
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential. | MedComm (2020) | 2023 | 37799806 | PubTator, text mining | PubMed |
| Erdr1 orchestrates macrophage polarization and determines cell fate via dynamic interplay with YAP1 and Mid1. | bioRxiv | 2023 | 37781614 | PubTator, text mining | PubMed |
| Synergistic effect of YOD1 and USP21 on the Hippo signaling pathway. | Cancer Cell Int | 2023 | 37743467 | PubTator, text mining | PubMed |
| The TRIM69-MST2 signaling axis regulates centrosome dynamics and chromosome segregation. | Nucleic Acids Res | 2023 | 37739411 | PubTator, text mining | PubMed |
| microRNAs delivered by small extracellular vesicles in MSCs as an emerging tool for bone regeneration. | Front Bioeng Biotechnol | 2023 | 37720323 | PubTator, text mining | PubMed |
| NRP1 transduces mechanical stress inhibition via LATS1/YAP in hypertrophic scars. | Cell Death Discov | 2023 | 37704618 | PubTator, text mining | PubMed |
| Inhibition of the interaction between Hippo/YAP and Akt signaling with ursolic acid and 3'3-diindolylmethane suppresses esophageal cancer tumorigenesis. | Korean J Physiol Pharmacol | 2023 | 37641811 | PubTator, text mining | PubMed |
| Evaluating the Molecular Properties and Function of ANKHD1, and Its Role in Cancer. | Int J Mol Sci | 2023 | 37629022 | PubTator, text mining | PubMed |
| A Comprehensive Insight and Mechanistic Understanding of the Lipidomic Alterations Associated With DCM. | JACC Asia | 2023 | 37614533 | PubTator, text mining | PubMed |
| Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2023 | 37608027 | PubTator, text mining | PubMed |
The impact of interaction between verteporfin and yes-associated protein 1/transcriptional coactivator with PDZ-binding motif-TEA domain pathway on the progression of isocitrate dehydrogenase wild-type glioblastoma. | J Cent Nerv Syst Dis | 2023 | 37600236 | PubTator, text mining | PubMed |
| The circadian clock protein Cryptochrome 1 is a direct target and feedback regulator of the Hippo pathway. | iScience | 2023 | 37593458 | PubTator, text mining | PubMed |
| YAP/TAZ: Molecular pathway and disease therapy. | MedComm (2020) | 2023 | 37576865 | PubTator, text mining | PubMed |
| Transposon delivery for CRISPR-based loss-of-function screen in mice identifies NF2 as a cooperating gene involved with the canonical WNT signaling molecular class of hepatocellular carcinoma. | Heliyon | 2023 | 37576222 | PubTator, text mining | PubMed |
| Endothelial TAZ inhibits capillarization of liver sinusoidal endothelium and damage-induced liver fibrosis via nitric oxide production. | Theranostics | 2023 | 37554269 | PubTator, text mining | PubMed |
| Cardiomyocyte proliferation is suppressed by ARID1A-mediated YAP inhibition during cardiac maturation. | Nat Commun | 2023 | 37543677 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
| CircAFF1 Is a Circular RNA with a Role in Alveolar Rhabdomyosarcoma Cell Migration. | Biomedicines | 2023 | 37509532 | PubTator, text mining | PubMed |
| Serine/Threonine Protein Kinase-3 Promotes Oral Squamous Cell Carcinoma by Activating Ras-MAPK Mediated Cell Cycle Progression. | Int J Gen Med | 2023 | 37496599 | PubTator, text mining | PubMed |
| Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target. | Front Oncol | 2023 | 37476371 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/60485/papers?page=6